Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Biallelic BICD2 variant is a novel candidate for Cohen-like syndrome.
Caglayan AO, Tuysuz B, Gül E, Alkaya DU, Yalcinkaya C, Gleeson JG, Bilguvar K, Gunel M. Caglayan AO, et al. Among authors: gul e. J Hum Genet. 2022 Sep;67(9):553-556. doi: 10.1038/s10038-022-01032-1. Epub 2022 Mar 25. J Hum Genet. 2022. PMID: 35338243 Free PMC article.
Physician Preferences in Using Novel Digital Devices for the Management of Atrial Fibrillation-A DAS-CAM III Survey.
Manninger M, Zweiker D, Hovakimyan T, Matusik PT, Conti S, Ollitrault P, Aro A, Mulder BA, Dichtl W, Heeger CH, Ter Bekke R, Gul EE, Weijs B, Rahm AK, Darma A, Evranos B, Sabbag A, Moroka K, Traykov V, Larsen JM, Amoroso GR, Evens S, McIntyre WF, Linz D. Manninger M, et al. Among authors: gul ee. Clin Cardiol. 2024 Dec;47(12):e24331. doi: 10.1002/clc.24331. Clin Cardiol. 2024. PMID: 39582318 Free PMC article.
Disease Characteristics and Outcomes of 493 Young Myeloma Patients Treated With Modern Therapies: A Canadian Myeloma Research Group Database Study.
Tanguay M, Roy J, Su J, Gul E, Reece D, Venner CP, White D, Chu MP, Jimenez-Zepada VH, Song K, Mccurdy A, Mian H, Sebag M, Bergstrom D, Stakiw J, Reiman A, Kotb R, Aslam M, Kaedbey R, Louzada M, LeBlanc R. Tanguay M, et al. Among authors: gul e. Cancer Med. 2024 Nov;13(21):e70332. doi: 10.1002/cam4.70332. Cancer Med. 2024. PMID: 39499045 Free PMC article.
Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial.
McCurdy A, Reece D, Louzada ML, White D, Parkin S, Chu MP, Kotb R, Mian H, Othman I, Su J, Khan A, Gul E, Trudel S. McCurdy A, et al. Among authors: gul e. Blood Cancer J. 2024 Sep 11;14(1):155. doi: 10.1038/s41408-024-01135-2. Blood Cancer J. 2024. PMID: 39261451 Free PMC article. Clinical Trial.
257 results